VIDEO: The latest in lipid-lowering therapy at NLA with Christie M. Ballantyne
Click Here to Manage Email Alerts
Key takeaways:
- There is much research activity in the lipid field.
- The National Lipid Association Scientific Sessions are covering a wide range of topics from cholesterol to precision medicine.
In this Healio | Cardiology Today video exclusive, Christie M. Ballantyne, MD, FACC, FACP, FAHA, FNLA, provided a review of the NLA Scientific Session opening session, “The Latest in Lipid Lowering Therapy – It's Not Just a Phase.”
The opening session included presentations on contemporary trials in familial hypercholesterolemia, triglycerides trials, lipoprotein(a) trials and emerging nonstatin LDL-lowering agents.
Ballantyne, who is chief of the section of cardiovascular research and professor of medicine at Baylor College of Medicine, said, “We covered the whole range from cholesterol trials, triglycerides to Lp(a) and precision medicine concepts ... it was just a great opening session.”
Watch the video for more.
References:
- Ahmad Z. Triglycerides Trials. Presented at: National Lipid Association Scientific Sessions; June 1-4, 2023; Atlanta, Georgia (hybrid meeting).
- Brown AS. Lipoprotein(a) Trials. Presented at: National Lipid Association Scientific Sessions; June 1-4, 2023; Atlanta, Georgia (hybrid meeting).
- Safarova MS. Lipid Disorder in The Age of Geonomics: Emerging Non-Statin LDL Lowering Agents. Presented at: National Lipid Association Scientific Sessions; June 1-4, 2023; Atlanta, Georgia (hybrid meeting).
- Shapiro M. Contemporary Clinical Trials in Familial Hypercholesterolemia. Presented at: National Lipid Association Scientific Sessions; June 1-4, 2023; Atlanta, Georgia (hybrid meeting).
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts